临床化学分析仪市场规模、份额、成长分析、按产品、按测试类型、按地区 - 产业预测，2024-2031 年

2022年全球临床生化分析仪市场规模预计为128亿美元，从2023年的134.5亿美元成长到2031年的200.2亿美元，预测期（2024-2031年）预计复合年增长率为5.1%。

由于诊断测试需求的增加和慢性病盛行率的增加，全球临床化学分析仪市场正在显着成长。这些分析仪对于测量生物样本中的化学成分非常重要，特别是随着人口老化增加糖尿病和心血管疾病等疾病的盛行率。技术进步，包括增强的演算法和自动化，进一步提高了准确性和效率，并提高了采用率。然而，高昂的初始成本和维护成本等挑战可能会限制其使用，特别是在发展中地区的小型实验室中。此外，检查过程的复杂性和监管要求的严格性需要熟练的人员并遵守品质标准，这使相关人员的市场环境变得复杂。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

临床化学分析仪市场规模：依产品及复合年增长率（2024-2031）

• 试剂
  • 校准器
  • 控制
  • 标准
  • 其他的
• 分析仪
  • 小型
  • 中等尺寸
  • 大的
  • 特大号
• 其他产品

临床化学分析仪市场规模：按测试类型和复合年增长率（2024-2031）

• 基础代谢组
• 肝臟组
• 肾臟面板
• 血脂谱
• 甲状腺功能检查
• 电解质板
• 特殊化学测试

临床化学分析仪市场规模：依最终用户和复合年增长率（2024-2031）

• 医院和诊所
• 诊断实验室
• 实验室/研究机构
• 其他最终用户

临床化学分析仪市场规模：按地区及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Thermo Fisher Scientific, Inc.
• Danaher Corporation（Beckman Coulter）
• Abbott
• Siemens Healthineers AG
• F. Hoffmann-La Roche Ltd
• HORIBA, Ltd.
• QuidelOrtho Corporation
• Randox Laboratories Ltd
• Hitachi Ltd.
• EKF Diagnostics
• Sysmex Corporation
• Mindray Medical International
• Biobase Group
• SFRI
• Trivitron Healthcare Pvt. Ltd.
• Randox Laboratories Ltd
• Medica Corporation

结论和建议

Global Clinical Chemistry Analyzers Market size was valued at USD 12.8 billion in 2022 and is poised to grow from USD 13.45 billion in 2023 to USD 20.02 billion by 2031, growing at a CAGR of 5.1% during the forecast period (2024-2031).

The global clinical chemistry analyzers market has seen substantial growth, largely fueled by rising diagnostic test demand and the increasing prevalence of chronic diseases. These analyzers are critical in measuring chemical components in biological samples, especially as the elderly population grows, leading to heightened incidences of conditions like diabetes and cardiovascular diseases. Technological advancements, including enhanced algorithms and automation, have further improved their accuracy and efficiency, promoting wider adoption. However, challenges such as high initial and maintenance costs can restrict access for smaller laboratories, particularly in developing regions. Additionally, the complexity of the testing process and stringent regulatory requirements necessitate skilled personnel and adherence to quality standards, complicating the market landscape for stakeholders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Chemistry Analyzers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Chemistry Analyzers Market Segmental Analysis

Global Clinical Chemistry Analyzers Market is segmented by Product, Test Type, End User and Region. Based on Product, the market is segmented into Reagents, Analyzers, Other Products. Based on Test Type, the market is segmented into Basic Metabolic Panels, Liver Panels, Renal Panels, Lipid Profiles, Thyroid Function Panels, Electrolyte Panels, Specialty Chemical Tests. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Research Laboratories & Institutes, Other End Users. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Global Clinical Chemistry Analyzers Market

One of the primary catalysts for growth in the Global Clinical Chemistry Analyzers market is the surging prevalence of chronic diseases, including diabetes, cardiovascular ailments, and renal disorders. As these health issues become more widespread, there is an increased need for accurate diagnostics and ongoing monitoring, which clinical chemistry analyzers facilitate. These sophisticated devices are essential for testing and analyzing biological samples, thereby enhancing the ability to track disease progression and treatment efficacy. Consequently, the escalating incidence of these conditions significantly fuels the demand for advanced clinical chemistry analyzers, marking a pivotal trend in the market's development.

Restraints in the Global Clinical Chemistry Analyzers Market

The global clinical chemistry analyzers market faces significant constraints due to stringent regulatory requirements and quality control measures. Adhering to these regulations can prove to be complex and time-consuming, which adds to the overall costs associated with product development and commercialization. Manufacturers often encounter challenges in navigating the regulatory landscape, leading to delays in bringing new products to market. Consequently, the intricate compliance process can hinder innovation and result in increased financial burdens, ultimately stifling growth potential within the clinical chemistry analyzers sector. These challenges underline the need for efficient strategies to streamline compliance efforts while ensuring product safety and efficacy.

Market Trends of the Global Clinical Chemistry Analyzers Market

The Global Clinical Chemistry Analyzers market is witnessing a significant trend towards point-of-care testing (POCT), fueled by the rising demand for rapid diagnostic results and the shift towards decentralized testing environments. As healthcare systems increasingly prioritize timely decision-making, compact and portable clinical chemistry analyzers are being embraced for their capability to facilitate on-site testing. This trend enhances the efficiency of healthcare delivery, enabling providers to promptly diagnose and treat conditions, thereby improving patient outcomes. The growing emphasis on personalized medicine and efficient healthcare services further bolsters the expansion of POCT, positioning it as a key driver of market growth in the clinical chemistry sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Clinical Chemistry Analyzers Market Size by Product & CAGR (2024-2031)

• Reagents
  • Calibrators
  • Controls
  • Standards
  • Others
• Analyzers
  • Small
  • Medium
  • Large
  • Very Large
• Other Products

Global Clinical Chemistry Analyzers Market Size by Test Type & CAGR (2024-2031)

• Basic Metabolic Panels
• Liver Panels
• Renal Panels
• Lipid Profiles
• Thyroid Function Panels
• Electrolyte Panels
• Specialty Chemical Tests

Global Clinical Chemistry Analyzers Market Size by End User & CAGR (2024-2031)

• Hospitals and Clinics
• Diagnostic Laboratories
• Research Laboratories & Institutes
• Other End Users

Global Clinical Chemistry Analyzers Market Size by Region & CAGR (2024-2031)

• North America, (by Product, by Test Type, by End User)
  • US
  • Canada
• Europe, (by Product, by Test Type, by End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (by Product, by Test Type, by End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (by Product, by Test Type, by End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (by Product, by Test Type, by End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Beckman Coulter)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HORIBA, Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd
• Hitachi Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biobase Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SFRI
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation